On today’s Executive Dose, host Stephen Beckman is joined by Representative Charity Grimm Krupa, who serves Pennsylvania’s 51st District in the House of Representatives, for a timely and insightful discussion on the evolving healthcare policy landscape in the Commonwealth. Together, they explore recent legislative developments in Pennsylvania that are shaping healthcare delivery, access, and affordability, with a particular focus on how state-level decisions often serve as early indicators for broader national trends. Stephen and Representative Grimm Krupa also examine the ripple effects Pennsylvania healthcare policy can have beyond state borders, highlighting why pharmacists, healthcare leaders, and industry stakeholders across the country should be paying close attention. From regulatory considerations to workforce challenges and patient-centered care initiatives, this episode offers valuable perspective on the intersection of policy, leadership, and healthcare innovation—and what it could mean for the future of healthcare nationwide.

I was blown away by today’s guest in his ability to educate on complex mechanisms of actions, as well as his innovation and humility. We touched on so many topics that I had to split this episode in two parts! It was truly reassuring and empowering to learn about healing with natural, science-backed tools to reduce inflammation, the hidden root cause of aging, chronic disease, and cancer. In these two episodes, you will learn how inflammation impacts health at a cellular level and how you can take proactive steps to restore vitality, strengthen immunity, and age with resilience. Samuel Shepherd is an award winning physicist, inventor, and engineer with 42 patents and over 50 years of breakthroughs across biochemical, environmental, and medical engineering. His career has taken him from developing technologies for NASA and the Beijing Olympics to pioneering solutions in alternative energy and environmental remediation. But it was a deeply personal health challenge that led him to his most life-changing discovery. In 2003, Samuel was diagnosed with a rare, untreatable bone marrow cancer. Conventional medicine offered no viable path forward, so he turned to his lifelong expertise in science and innovation. After years of research, he developed ValAsta, the only patented glycosidic form of astaxanthin designed specifically to target inflammation, the root cause of most chronic disease. His unique delivery system makes astaxanthin far more bioavailable than typical supplements, producing remarkable results for energy, mobility, sleep, and overall vitality in both people and pets. Today, Samuel is on a mission to educate others about how inflammation accelerates disease and diminishes quality of life, and how targeted natural solutions can restore health. Beyond his formidable credentials, his personal story of overcoming terminal illness fuels his passion for helping others age with strength, energy, and resilience. Connect with Samuel via: Email: info@valasta.net Website: ValAsta FB: ValAsta Youtube: @ValAsta Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Opioidology Part 3: Opioid-Philia vs Opioid-Phobia The often-blurred lines of pain, addiction, and substance use need a deeper dive into the extremes of opioid-philia and opioid-phobia (building upon Opioidology Part 1: Our Opioid Story). Join Mark “Pain Guy” Garofoli and our two guests James Hackworth and Jim Potenziano to take that deeper dive based on their recent collaboration in the Frontiers in Pain Research article “The Burden of Acute Pain in the U.S. in the Wake of the Opioid Crisis”. • Frontiers in Pain Research Article: https://www.frontiersin.org/journals/pain-research/articles/10.3389/fpain.2025.1642035/full • Article Key Takeaways • Rising Pain Prevalence • Balancing Act—Opioid Utilization vs. Undertreatment • Provider Reluctance to use opioids • Patient Reluctance • Massive Economic Impact • Call for Innovation & Policy Reform • Opioid Story charts: www.painguy.us